Global Brain has invested in Meta Flow Ltd. (Meta Flow), the startup behind “Lumen,” a service improving metabolic health using a device and app, through its KIRIN HEALTH INNOVATION FUND. Meta Flow is the company behind “Lumen,” the first handheld device to measure your metabolism through your breath. “Lumen” reveals the state of your metabolism and shows you the impact of your nutrition and lifestyle on your body, as well as provides valuable scientific data to increase knowledge of metabolic flexibility and nutrition. In a published clinical trial*, prediabetic patients who used “Lumen” demonstrated a significant health improvement in key metabolic parameters such as lower Hb1c levels or fasting glucose, body weight, and body fat reduction. *Assaf Buch et al, Obes Facts (2023) 16 (1): 53–61. “Lumen” is the largest platform to measure metabolism in the world with its primary customary base in the US. Meta Flow will pursue further development of the device and app to help users make smarter decisions about their nutrition and lifestyle habits. Global Brain has decided to invest in Meta Flow because of its high-quality service, great management team, and huge potential in the wellness market. Through this investment, Global Brain will contribute to the business expansion of Meta Flow in collaboration with Kirin Holdings.

About Meta Flow

Location: Tel-Aviv, Israel
CEO: Daniel Tal Mor
Founded: January 2014
URL: https://www.lumen.me/

About KIRIN HEALTH INNOVATION FUND

Name: KIRIN-GB Fund I L.P.
General Partner: Global Brain Corporation
Fund Size: JPY 5 billion
Fund Term: 10 years

About Global Brain

Location: Tokyo, Japan
Representative: Yasuhiko Yurimoto
Founded: January 1998
URL: https://globalbrains.com/

Global Brain has invested in Meta Flow Ltd., the startup behind “Lumen,” a service improving metabolic health using a device and app